Publicaciones en colaboración con investigadores/as de University of Liverpool (13)

2026

  1. Antiphospholipid antibodies and cardiovascular thrombosis

    Nature Reviews Cardiology

  2. Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial

    European Radiology

  3. Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy

    Clinical and Translational Radiation Oncology, Vol. 58

  4. Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC

    ESMO Open, Vol. 11, Núm. 2

2025

  1. Health Status Outcomes After Computed Tomography or Invasive Coronary Angiography for Stable Chest Pain A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial

    JAMA Cardiology, Vol. 10, Núm. 7, pp. 728-739

  2. Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials

    Thrombosis Research, Vol. 255

2024

  1. Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

    The European respiratory journal, Vol. 63, Núm. 6

  2. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592

  3. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639